SCHEMBL1704656

SCHEMBL1704656

C=C(C(=O)O)C(N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL738870 0.75
SCHEMBL4632171 0.75 GRIK1 (0.42)
SCHEMBL18277715 0.75 GRIK1 (0.42)
SCHEMBL5293647 0.75 GRIK1 (0.42)
SCHEMBL7997976 0.73
SCHEMBL523207 0.73 SLC7A5 (0.57)
Chloromethane SCHEMBL7216949 0.71 SLC7A5 (0.42)
SCHEMBL45773 0.71
SCHEMBL1275232 0.69
SCHEMBL1512900 0.69 SLC7A5 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191085-B1 ABUSE RESISTANT PHARMACEUTICAL COMPOSITIONS RECRO GAINESVILLE LLC (US) 2021-03-24 EP claimed
EP-2557924-B1 DERMAL PHARMACEUTICAL COMPOSITIONS OF 1-METHYL-2',6'-PIPECOLOXYLIDIDE AND METHOD OF USE RELMADA THERAPEUTICS INC (US) 2019-06-12 EP claimed
EP-2568964-B1 PHARMACEUTICAL DOSAGE FORM COMPRISING ONE OR MORE ANTIRETROVIRAL ACTIVE INGREDIENTS EVONIK ROEHM GMBH (DE) 2018-08-01 EP claimed
EP-2482822-B1 ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS ADARE PHARMACEUTICALS INC (US) 2018-08-01 EP claimed
EP-2506836-B1 FEXOFENADINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEM ADARE PHARMACEUTICALS S R L (IT) 2018-02-14 EP claimed
EP-2538928-B1 ABUSE-RESISTANT FORMULATIONS CIMA LABS INC (US) 2017-05-03 EP claimed
EP-2007378-B1 PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND LIPOPHILIC OIL ABSORBENT AND ORAL FORMULATION PREPARED THEREFROM AMOREPACIFIC CORP (KR) 2016-03-30 EP claimed
EP-2651390-B1 ZOLPIDEM-BASED ORODISPERSIBLE PHARMACEUTICAL TABLET SANOFI SA (FR) 2015-05-27 EP claimed
EP-1351668-B1 SUSTAINED RELEASE PHARMACEUTICAL DOSAGE FORMS WITH MINIMIZED PH DEPENDENT DISSOLUTION PROFILES SUPERNUS PHARMACEUTICALS INC (US) 2014-10-15 EP claimed
EP-2578208-B1 DPP-IV inhibitor solid dosage formulations SANOVEL ILAC SANAYI VE TICARET (TR) 2014-05-21 EP claimed
EP-1726331-B1 Moisture resistant hair styling composition containing two copolymers WELLA AG (DE) 2008-11-12 EP claimed
EP-1126826-B1 MULTIPARTICULATE MODIFIED RELEASE COMPOSITION OF METHYLPHENIDATE ELAN PHARMA INT LTD (IE) 2008-10-15 EP claimed
EP-1591109-B1 Formulation comprising histone deacetylase inhibitor exhibiting biphasic release TOPOTARGET GERMANY AG (DE) 2008-07-02 EP claimed
EP-0553392-B2 Method for obtaining a Stabilized controlled release formulations having acrylic polymer coating EURO CELTIQUE SA (LU) 2007-12-05 EP claimed
EP-1178780-B1 MULTIPARTICULATE CONTROLLED RELEASE SELECTIVE SEROTONIN REUPTAKE INHIBITOR FORMULATIONS ELAN CORP PLC (IE) 2007-07-18 EP claimed
EP-1691892-B1 TAMPER RESISTANT CO-EXTRUDED DOSAGE FORM CONTAINING AN ACTIVE AGENT AND AN ADVERSE AGENT AND PROCESS OF MAKING SAME EURO CELTIQUE SA (LU) 2007-02-28 EP claimed
EP-1143963-B1 MULTIPARTICULATE BISOPROLOL FORMULATION ATHPHARMA LTD (IE) 2006-06-14 EP claimed
EP-1191926-B1 NEW OMEPRAZOLE AND (S)-OMEPRAZOLE FORMULATION ASTRAZENECA AB (SE) 2005-03-30 EP claimed
EP-0896823-B1 Improved stabilization of Misoprostol DEV CENTER BIOTECHNOLOGY (TW) 2002-09-25 EP claimed
EP-0878319-B1 Recording material for ink jet printing SCHOELLER FELIX JUN FOTO (DE) 2001-10-24 EP claimed